SCHEMBL3655052

SCHEMBL3655052

COC(=O)[C@@]12CC[C@@H](C[C@H](c3ccc(I)cc3)C1)N2C

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 11/20 0.41
SLC6A3 Q01959 11/20 0.41
SLC6A2 P23975 8/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23924861 0.89 SLC6A3 (0.40) SLC6A4SLC6A3SLC6A2
SCHEMBL8481404 0.88 OPRK1 (0.42) SLC6A4SLC6A3SLC6A2
SCHEMBL30899722 0.88 OPRK1 (0.42) SLC6A4SLC6A3SLC6A2
SCHEMBL30198388 0.88 SLC6A4 (0.41) SLC6A4SLC6A3SLC6A2
SCHEMBL1012742 0.88 MEN1 (0.40) SLC6A4SLC6A3SLC6A2
SCHEMBL4591521 0.82 SLC6A3 (0.45) SLC6A4SLC6A3
SCHEMBL4592572 0.75 MTNR1A (0.39) SLC6A4
SCHEMBL9405512 0.74 DRD2 (0.38) SLC6A4SLC6A3SLC6A2
SCHEMBL9405511 0.74 DRD2 (0.38) SLC6A4SLC6A3SLC6A2
SCHEMBL7349981 0.74 LMNA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4164665-A1 ENGINEERED MICROORGANISMS FOR DIAGNOSTIC IMAGING Microbial Machines, Inc. (US) 2023-04-19 EP disclosed
US-20230001026-A1 PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT ADMINISTRATION OF RADIOTRACERS LIKEMINDS, INC. 2023-01-05 US disclosed
US-20210322463-A1 METHOD FOR ACCELERATED TISSUE PENETRATION OF COMPOUNDS INTO BRAIN LIKEMINDS INC (US) 2021-10-21 US disclosed
EP-3833403-A1 METHOD FOR DIAGNOSIS OF DOPAMINERGIC AND MOVEMENT DISORDERS Likeminds, Inc. (US) 2021-06-16 EP disclosed
US-20210162078-A1 METHOD FOR DIAGNOSIS OF DOPAMINERGIC AND MOVEMENT DISORDERS LIKEMINDS, INC. 2021-06-03 US disclosed
WO-2021102323-A1 PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT ADMINISTRATION OF RADIOTRACERS LIKEMINDS, INC. (US) 2021-05-27 WO disclosed
EP-3823679-A1 METHOD FOR ACCELERATED TISSUE PENETRATION OF COMPOUNDS INTO BRAIN Likeminds, Inc. (US) 2021-05-26 EP disclosed
WO-2020033523-A1 METHOD FOR DIAGNOSIS OF DOPAMINERGIC AND MOVEMENT DISORDERS LIKEMINDS, INC. (US) 2020-02-13 WO disclosed
WO-2020018743-A1 METHOD FOR ACCELERATED TISSUE PENETRATION OF COMPOUNDS INTO BRAIN LIKEMINDS, INC. (US) 2020-01-23 WO disclosed
EP-2212320-A1 CHEMICAL SYNTHESIS OF I-124BETA CIT IODINE-124 [2-BETA-CARBOMETHOXY-3BETA- (4. -IODOPHENYL) -TROPANE] FOR PET INVESTIGATIONS AND FOR RADIOTHERAPY A.C.O.M. Advanced Center Oncology Macerata S.p.a. (IT) 2010-08-04 EP disclosed
EP-2212320-A1 CHEMICAL SYNTHESIS OF I-124BETA CIT IODINE-124 [2-BETA-CARBOMETHOXY-3BETA- (4. -IODOPHENYL) -TROPANE] FOR PET INVESTIGATIONS AND FOR RADIOTHERAPY A.C.O.M. Advanced Center Oncology Macerata S.p.a. (IT) 2010-08-04 EP disclosed
WO-2009143985-A1 NEW MOLECULE 5-HYDROXY-L-(4-HYDROXY-3-[124I]IODO-5-METHOXYPHENYL)-7- (4-HYDROXY-3-METHOXYPHENYL)-L,4,6-HEPTATRIEN-3-ONE FOR PET INVESTIGATIONS AND RADIOTHERAPY. SPARKLE S.R.L. (IT) 2009-12-03 WO disclosed
WO-2009141137-A2 NEW MOLECULE [124I][2-(3'-IODO-4'-METHYLAMINOPHENYL)-6-HYDROXY-BENZOTHIALZOLE] FOR PET INVESTIGATIONS AND RADIOTHERAPY SPARKLE S.R.L. (IT) 2009-11-26 WO disclosed
WO-2009046897-A1 CHEMICAL SYNTHESIS OF I-124BETA CIT IODINE-124 [2-BETA-CARBOMETHOXY-3BETA- (4. -IODOPHENYL) -TROPANE] FOR PET INVESTIGATIONS AND FOR RADIOTHERAPY A.C.O.M ADVANCED CENTER ONCOLOGY MACERATA S.P.A. (IT) 2009-04-16 WO disclosed
WO-2009046897-A1 CHEMICAL SYNTHESIS OF I-124BETA CIT IODINE-124 [2-BETA-CARBOMETHOXY-3BETA- (4. -IODOPHENYL) -TROPANE] FOR PET INVESTIGATIONS AND FOR RADIOTHERAPY A.C.O.M ADVANCED CENTER ONCOLOGY MACERATA S.P.A. (IT) 2009-04-16 WO disclosed
US-5569447-A TOMOGRAPHIC IMAGING AGENTS THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-10-29 US disclosed